
Sanofi
SNYNF | OTC
$85.35
+$1.46 (+1.73%)
At close: Sep 21, 2026, 2:28 PM ET
$85.35
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 44.29B | 46.44B | 40.3B | 39.18B | 37.37B | 37.63B |
Cost of Revenue | 13.21B | 14.24B | 13.7B | 12.26B | 12.16B | 11.98B |
Gross Profit | 31.08B | 32.21B | 31.69B | 26.92B | 25.21B | 25.66B |
Operating Income | 14.45B | 12.98B | 13.15B | 8.13B | 14.14B | 3.13B |
Interest Income | 413M | 19M | 239M | 3M | 53M | 141M |
Pretax Income | 6.76B | 6.12B | 9.99B | 7.8B | 14.14B | 2.82B |
Net Income | 5.56B | 5.4B | 8.37B | 6.22B | 12.29B | 2.81B |
Selling & General & Admin | 9.18B | 10.77B | 8.79B | 9.56B | 9.39B | 9.88B |
Research & Development | 7.39B | 6.73B | 6.5B | 5.69B | 5.53B | 6.02B |
Other Expenses | 7.25B | 6.84B | n/a | 3.55B | -3.82B | 2.53B |
Operating Expenses | 23.83B | 24.33B | 15.29B | 18.79B | 11.1B | 18.43B |
Interest Expense | 749M | 710M | 465M | 368M | 390M | 444M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 9.39B | 9.88B |
Cost & Expenses | 37.03B | 38.57B | 27.16B | 31.05B | 23.26B | 30.41B |
Income Tax Expense | 1.2B | 1.02B | 1.91B | 1.56B | 1.81B | 139M |
Shares Outstanding (Basic) | 1.25B | 1.26B | 1.25B | 1.25B | 1.25B | 1.25B |
Shares Outstanding (Diluted) | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B |
EPS (Basic) | 4.45 | 4.30 | 6.69 | 4.97 | 9.81 | 2.33 |
EPS (Diluted) | 4.43 | 4.30 | 6.66 | 4.95 | 9.76 | 2.31 |
EBITDA | 11.03B | 11.08B | 13.51B | 11.25B | 10.47B | 10.66B |
EBIT | 7.45B | 8.12B | 10.4B | 8.57B | 14.21B | 3.22B |
Depreciation & Amortization | 3.59B | 2.96B | 3.11B | 2.69B | 2.89B | 3.75B |
Add to Watchlist
Select watchlists to add or remove SNYNF